DENVER, June 22,
2022 /PRNewswire/ -- DaVita Inc. (NYSE: DVA),
announced today it will hold a special conference call with
investors on Thursday, June 23, 2022, at 8:45 a.m.
Eastern Time. This call follows this week's U.S. Supreme Court
ruling regarding the Medicare Secondary Payor Act.
You can join this call as follows:
Thursday, June 23, 2022
Starting at 8:45 a.m. EDT
Dial in number: 877-918-6630
International dial in: 517-308-9042
Webcast: investors.davita.com
When calling in, please provide the operator the password
"DaVita" and provide your name and company affiliation. Investors
unable to listen to the conference call will be able to access a
replay via our website at investors.davita.com. There will be no
telephone replay.
About DaVita Inc. DaVita (NYSE: DVA) is a
comprehensive kidney care provider focused on transforming care to
improve the quality of life for patients globally. The company is a
leading provider of kidney care services in the U.S. and has been a
leader in clinical quality and innovation for more than 20 years.
DaVita is working to help increase equitable access to care for
patients at every stage and setting along their kidney health
journey—from slowing progression of kidney disease to streamlining
the transplant process, from acute hospital care to dialysis at
home. As of March 31, 2022, DaVita served 200,800
patients at 2,809 outpatient dialysis centers in the U.S. The
company operated an additional 346 outpatient dialysis centers in
11 other countries worldwide. DaVita has reduced hospitalizations,
improved mortality and worked collaboratively to help propel the
kidney care community to adopt an equitable, high-quality standard
of care for patients around the globe. To learn more,
visit DaVita.com/About.
Contact Information
Investors:
IR@davita.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/davita-inc-schedules-special-investor-conference-call-301573212.html
SOURCE DaVita Inc.